Related Experiment Video
Updated: Mar 29, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
SnapShot: Renal Cell Carcinoma
Samra Turajlic1, James Larkin2, Charles Swanton3
1The Francis Crick Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK; Renal Unit, The Royal Marsden Hospital, London SW3 6JJ, UK.
Abstract:
This SnapShot summarizes current knowledge about the key features in mutational landscape, major pathways, and tumor evolution and heterogeneity in renal cell carcinoma, as well as the most recent advances in therapeutic development. To view this SnapShot, open or download the PDF.
Insights
This review covers the mutational landscape, pathways, tumor evolution, and heterogeneity in renal cell carcinoma (RCC). It also highlights recent therapeutic advances for this complex cancer.
Area of Science:
- Oncology
- Genetics
- Cancer Research
Background:
- Renal cell carcinoma (RCC) is a significant global health concern.
- Understanding the genetic underpinnings and tumor progression of RCC is crucial for effective treatment.
Purpose of the Study:
- To provide a comprehensive overview of the current knowledge on RCC.
- To summarize key features of RCC's mutational landscape, major pathways, and tumor evolution.
- To highlight recent therapeutic developments in managing RCC.
Main Methods:
- This work is a summary and synthesis of existing research and clinical data.
- Literature review of peer-reviewed publications and clinical trial outcomes.
- Analysis of current trends in renal cell carcinoma research.
Main Results:
- RCC exhibits a complex mutational landscape with distinct molecular subtypes.
- Key signaling pathways implicated in RCC pathogenesis have been identified.
- Tumor evolution and heterogeneity present significant challenges in RCC treatment.
Conclusions:
- Advances in understanding RCC genetics and evolution are paving the way for targeted therapies.
- Personalized treatment strategies are emerging for renal cell carcinoma.
- Continued research is essential to overcome therapeutic resistance in RCC.
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Chronic Kidney Disease I: Introduction
Urinary Tract Calculi I: Introduction
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Nephrons